BioAge Labs Inc.(BIOA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BIOA BioAge Labs Inc.

已收盘 11-18 16:00:00 EST

18.12

-0.17

-0.93%

盘后19.02

+0.90+4.97%

19:09 EST

最高19.89	最低18.00	成交量16.98万
今开19.50	昨收18.29	日振幅10.35%
总市值6.50亿	流通市值1.90亿	总股本3,585万
成交额313.25万	换手率1.62%	流通股本1,050万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BIOA","market":"US","secType":"STK","nameCN":"BioAge Labs Inc.","latestPrice":18.12,"timestamp":1731963600000,"preClose":18.29,"halted":0,"volume":169789,"hourTrading":{"tag":"盘后","latestPrice":19.02,"preClose":18.12,"latestTime":"19:09 EST","volume":1106,"amount":20144.31,"timestamp":1731974975348},"delay":0,"floatShares":10500000,"shares":35848738,"eps":-33.128242,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.17,"latestTime":"11-18 16:00:00 EST","open":19.5,"high":19.8929,"low":18,"amount":3132495.8382050004,"amplitude":0.103494,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-33.128242,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732006800000},"adr":0,"listingDate":1727323200000,"adjPreClose":18.29,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":19.5,"preClose":18.29,"latestTime":"09:29 EST","volume":1167,"amount":22870.540407,"timestamp":1731940155053},"postHourTrading":{"tag":"盘后","latestPrice":19.02,"preClose":18.12,"latestTime":"19:09 EST","volume":1106,"amount":20144.31,"timestamp":1731974975348},"volumeRatio":0.887607},"requestUrl":"/m/hq/s/BIOA/wiki","defaultTab":"wiki","newsList":[{"id":"2477636551","title":"更新版 2-高盛支持的药物开发商 Septerna 在美国首次公开募股中目标估值 7.43 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477636551","media":"路透中文","labels":["Shareholding Changes","Product Release","event"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477636551?lang=zh_cn&edition=full","pubTime":"2024-10-24 20:08","pubTimestamp":1729771713,"startTime":"0","endTime":"0","summary":"更新版 2-高盛支持的药物开发商 Septerna 在美国首次公开募股中目标估值 7.43 亿美元第 3-5 段补充了生物技术行业的背景，第 6-7 段补充了 Septerna 的主要药物。路透10月24日 - 高盛支持的药物开发商赛普特纳公司周四表示，该公司将在美国进行规模更大的首次公开募股，寻求获得 7.431 亿美元的估值，这表明投资者对这一资本密集型行业的乐观情绪。高盛持有 Septerna 5.4% 的股份，该公司目前的目标是通过出售近 1530 万股每股 18 美元的股票筹集 2.75 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241024:nL4S3M01LN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes,Product Release,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443978.SGD","BK4552","LU0106831901.USD","LU1791807156.HKD","IE0002270589.USD","BK4588","BK4533","MBX","IE00BFXG1179.USD","BK4550","BK4127","LU2237443549.SGD","LU2237443622.USD","UPB","LU2237438978.USD","IE0034235188.USD","IE0004086264.USD","LU2237443895.HKD","BK4504","LU1668664300.SGD","IE0004091025.USD","BK4139","LU2237443465.HKD","BIOA","IE00BSNM7G36.USD","BCAX","LU2237443382.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","BK4007","BK4585"],"gpt_icon":0},{"id":"2477898085","title":"BUZZ--美国股票走势-豪迈航空航天公司、阿拉斯加航空公司、Arcus 生物科学公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2477898085","media":"Reuters","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477898085?lang=zh_cn&edition=full","pubTime":"2024-10-22 00:12","pubTimestamp":1729527131,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      10月21日 - 华尔街主要股指周一表现低迷，投资者在经历了前一周的大涨之后稍作喘息，等待各大公司的财报，这些财报可能会影响市场是维持纪录高位还是下跌。美东时间11:34，道琼斯工业平均指数  下跌0.9%，报42,881.14点。标普500指数  下跌0.63%，报5827.7点；纳斯达克综合指数  下跌0.50%，报18396.354点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DJX","DVN","JKS",".SPX","BK4561","HD","VFC","ALLY","DXD","PSN","BIOA","MGRX","CI","CTRA","LUMN","SCWX","AMRX","TARA","DDM","CRGY","KIRK","UPS","NEM","CVX","SDOW","APA","HUM","XOM",".IXIC",".DJI","RCUS","SEDG","SYTA","HTZ","HWM","INDB","RH","UDOW","VVI","ALK","PLL","SAVE","AUB","DOG"],"gpt_icon":1},{"id":"2477391868","title":"BUZZ--美国股票走势-BioAge Labs、Piedmont Lithium、联合包裹服务公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2477391868","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477391868?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:17","pubTimestamp":1729516656,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      10月21日 -    华尔街主要股指继前一周反弹后，周一准备下挫，在主要财报公布前，股指是从纪录高位回落还是维持上涨势头，可能会受到影响。美东时间9:02，道指电子盘  下跌0.12%，报43,466点。标普500指数小型股  下跌0.23%，报5892.25点；纳斯达克100指数小型股  下跌0.41%，报20398.5点。** Lumen Technologies Inc   ：盘前上涨18.1%BUZZ - 在宣布与Meta合作后上涨","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002232.USD","LU0612318971.USD","BK4100","ALLY","LU0496367417.USD","LU1430597077.USD","LU0211331839.USD","IE00B19Z3B42.SGD","KIRK","LU0170899867.USD","LU1894683348.USD","BK4532","LUMN","SYTA","HWM","LU0055631609.USD","LU0225284248.USD","INDB","SG9999013999.USD","LU0788108826.HKD","LU0300736492.USD","VVI","BK4551","LU1894683264.USD","PLL","LU0149725797.USD","IE00BJJMRY28.SGD","SEDG","BK4534","IE00B19Z3581.USD","LU2462611646.USD","IE00BJJMRX11.SGD","SAVE","MGRX","BK4554","LU0456855351.SGD","LU1023059063.AUD","UPS","LU1430594728.SGD","BIOA","LU1066051498.USD","IE00B7SZLL34.SGD","LU0320765646.SGD","LU1066053197.SGD","SG9999001176.SGD","NEM","LU0070302665.USD"],"gpt_icon":1},{"id":"2477856129","title":"BUZZ-杰富瑞首推 BioAge Labs，\"买入 \"新型肥胖症药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2477856129","media":"Reuters","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477856129?lang=zh_cn&edition=full","pubTime":"2024-10-21 19:34","pubTimestamp":1729510484,"startTime":"0","endTime":"0","summary":"    10月21日 - ** 杰富瑞给予药物开发商BioAge Labs   \"买入 \"评级，目标价42美元。** 经纪公司称，BIOA的主要候选药物azelaprag具有新颖的机制，可作为治疗肥胖症的常用GLP-1药物的补充疗法，有助于在竞争日益激烈的市场中满足某些未得到满足的需求。** 杰富瑞预测该药物的最高收入将达到近 20 亿美元；称它针对的是 \"能量消耗\"，而其他药物针对的是能量摄入** 根据早期数据，券商预计该药物与单独使用 Zepbound/Wegovy 相比，可以帮助减轻更多体重，而且副作用更小。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GB00BDT5M118.USD","LU0203201768.USD","LU0640476718.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0471298694.HKD","IE00BK4W5L77.USD","LU0203202063.USD","LU0109391861.USD","LU0198837287.USD","BK4533","BIOA","LU0823416689.USD","LU0094547139.USD","LU0354030511.USD","BK4585","LU0289739699.SGD","LU0354030438.USD","JEF","LU0238689110.USD","LU1093756168.USD","LU0672654240.SGD","IE0002141913.USD","IE00BJLML261.HKD","IE0004445239.USD","LU0114720955.EUR","BK4581","LU0097036916.USD","LU0471298777.SGD","LU0006306889.USD","LU0320765059.SGD","LU0943347566.SGD","LU0708995401.HKD","LU0820561909.HKD","LU1035775433.USD","LU1064131342.USD","LU0417517546.SGD","IE00B1BXHZ80.USD","BK4588","IE00B2B36J28.USD","LU0256863902.USD","LU0882574055.USD","LU1061106388.HKD","IE00BK4W5M84.HKD","LU0079474960.USD","LU0689472784.USD","LU0106261372.USD","BK4534","IE00B4R5TH58.HKD"],"gpt_icon":1},{"id":"2474031923","title":"更新版 2-随着医疗保健行业上市热潮的兴起，上游生物和另外两家美国生物技术初创公司纷纷定价 IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2474031923","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474031923?lang=zh_cn&edition=full","pubTime":"2024-10-11 08:01","pubTimestamp":1728604880,"startTime":"0","endTime":"0","summary":"更新版 2-随着医疗保健行业上市热潮的兴起，上游生物和另外两家美国生物技术初创公司纷纷定价 IPO全文改写；第 3-10 段增加了细节和背景介绍。路透10月11日 - 周四，三家美国医疗保健初创企业首次公开募股定价，其中包括Upstream Bio UPB.O，该公司以约8.3亿美元的估值募集了2.55亿美元。Dealogic 的数据显示，9 月份是今年医疗保健行业 IPO 最繁忙的月份。CAMP4 的首次公开募股定价为每股 11 美元，远低于其 14 至 16 美元的目标区间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241011:nL4T3LN006:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BCAX","BK4135","IPO","BK4139","TPG"],"gpt_icon":0},{"id":"2474225168","title":"更新版 2-TPG 支持的 CeriBell 在美国首次公开募股中寻求高达 5.78 亿美元的估值","url":"https://stock-news.laohu8.com/highlight/detail?id=2474225168","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474225168?lang=zh_cn&edition=full","pubTime":"2024-10-09 19:56","pubTimestamp":1728475011,"startTime":"0","endTime":"0","summary":"更新版 2-TPG 支持的 CeriBell 在美国首次公开募股中寻求高达 5.78 亿美元的估值CeriBell 发行 1,060 万股股票，此前为 670 万股首次公开募股价格区间从每股 14-16 美元提高到 16-17 美元部分现有投资者可购买价值高达 4000 万美元的股票在第 6、7 和 9-12 段增加了有关公司和首次公开募股的背景和详细信息。路透10月9日 - 由 TPG 支持的医疗设备制造商 CeriBell 周三表示，该公司将在美国进行规模更大的首次公开募股，目标估值高达 5.783 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241009:nL4T3LL12P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","BIOA","LU0868494617.USD","BK4588","LU1201861165.SGD","TPG","LU1668664300.SGD","LU0306806265.USD","LU1162221912.USD","BK4559","BK4207","BK4585","LU1074936037.SGD","LU0234572021.USD","IE00BLSP4239.USD","LU1496350502.SGD","LU0053666078.USD","LU1894683348.USD","LU0321505439.SGD","LU1280957306.USD","LU0256863811.USD","LU0980610538.SGD","BK4139","LU0640476718.USD","LU2129689514.USD","LU0128525689.USD","LU0310800965.SGD","IE00BZ1G4Q59.USD","LU0130103400.USD","IE00B19Z3581.USD","LU0648000940.SGD","LU0971096721.USD","BK4553","LU1267930227.SGD","LU1718418525.SGD","LU0321505868.SGD","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","LU1201861249.SGD","BAC","LU1894683264.USD","LU1791807156.HKD","LU1496350171.SGD","LU0417517546.SGD","BK4135","BCAX","BK4534","IE00BFXG1179.USD","BK4504","LU0070302665.USD"],"gpt_icon":0},{"id":"2473285107","title":"肥胖药物生产商Rivus据悉考虑最快今年上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2473285107","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473285107?lang=zh_cn&edition=full","pubTime":"2024-10-07 23:30","pubTimestamp":1728315048,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BIOA","161121","RA","IPO"],"gpt_icon":0},{"id":"1186878787","title":"异动解读 | 生物科技新星BioAge Labs纳斯达克上市首日大涨6.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=1186878787","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186878787?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:36","pubTimestamp":1727444184,"startTime":"0","endTime":"0","summary":"9月27日,生物科技新星BioAge Labs Inc.在美国纳斯达克交易所成功挂牌上市,股价大涨6.36%,收于38.74美元,引发市场广泛关注。BioAge Labs主攻代谢疾病等人类衰老相关疾病的治疗领域,其主要候选药物azelaprag在多项临床试验中表现出良好的安全性和有效性。此外,生物科技公司是今年美国IPO市场的一大亮点,活跃的IPO市场为BioAge Labs上市大涨提供了良好环境。投资者偏好盈利前景明朗的公司,生物科技龙头BioAge Labs自然成为资金追捧对象。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BIOA"],"gpt_icon":0},{"id":"1163589295","title":"异动解读 | 生物科技新星BioAge Labs纳斯达克挂牌上市 股价大涨5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=1163589295","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163589295?lang=zh_cn&edition=full","pubTime":"2024-09-27 20:56","pubTimestamp":1727441784,"startTime":"0","endTime":"0","summary":"生物科技新星BioAge Labs Inc.于2024年9月26日在美国纳斯达克交易所成功挂牌上市,首日股价大涨5.73%,反映了投资者对该公司未来发展前景的乐观预期。BioAge Labs主攻代谢疾病等人类衰老相关疾病的治疗领域,其主要候选药物azelaprag是一种口服小分子,已在多项临床试验中表现出良好的安全性和有效性。据招股书披露,BioAge Labs虽然暂无营收,但已累计获得超过3亿美元融资,投资者包括知名风险投资机构Andreessen Horowitz、Khosla Ventures等。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BIOA"],"gpt_icon":0},{"id":"2470743424","title":"《图表新闻》美国IPO市场稳健回升后将延续复苏势头","url":"https://stock-news.laohu8.com/highlight/detail?id=2470743424","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470743424?lang=zh_cn&edition=full","pubTime":"2024-09-27 10:56","pubTimestamp":1727405798,"startTime":"0","endTime":"0","summary":"《图表新闻》美国IPO市场稳健回升后将延续复苏势头路透9月26日 - 受经济衰退担忧消退和股市飙升的推动，美国首次公开发行市场在经历了近两年的枯竭期后，于2024年强劲反弹。作为趋势指标的Renaissance IPO指数 .FTIPOUSA，今年迄今为止上涨了约14%。**生技公司大放异彩**Dealogic的数据显示，9月成为今年医疗保健行业IPO最繁忙的月份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240927:nL6T3L9034:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","BKV","IPO","BIOA","GRDN","LINE","CON","RDDT","BK4224"],"gpt_icon":0},{"id":"2470971613","title":"生物科技公司BioAge Labs纳斯达克上市：市值6亿美元 路演PPT曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2470971613","media":"雷递网","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470971613?lang=zh_cn&edition=full","pubTime":"2024-09-27 09:01","pubTimestamp":1727398919,"startTime":"0","endTime":"0","summary":"生物科技初创公司BioAge Labs（股票代码为：“BIOA”）昨日在美国纳斯达克上市，募资总额为1.98亿美元。BioAge Labs开盘价为22.5美元，较发行价上涨25%；收盘价为18.31美元，较发行价上涨1.72%；以收盘价计算，公司市值为6.16亿美元。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20240927/6386302451252659998745633.png","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20240927/6386302451252659998745633.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.leinews.com/n27839/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["ARTL","03086","BK1147","QID","MNQmain","TQQQ","SQQQ","NQmain","PPT","PSQ","QLD","BK4007","BIOA",".IXIC"],"gpt_icon":1},{"id":"2470918745","title":"敬告客户-以下稿子现予以撤销-美国首次公开募股稳健反弹后将延续复苏势头","url":"https://stock-news.laohu8.com/highlight/detail?id=2470918745","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470918745?lang=zh_cn&edition=full","pubTime":"2024-09-27 02:41","pubTimestamp":1727376093,"startTime":"0","endTime":"0","summary":"敬告客户-以下稿子现予以撤销-美国首次公开募股稳健反弹后将延续复苏势头STORY_NUMBER: L4T3L81RQSTORY_DATE: 26/09/2024STORY_TIME: 1841 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240926:nL4T3L81RQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","LINE","BK4547","BKV","BK4077","BIOA","BK4224","RDDT","CON","GRDN"],"gpt_icon":0},{"id":"2470573367","title":"图形-美国首次公开募股稳健反弹后将延续复苏势头","url":"https://stock-news.laohu8.com/highlight/detail?id=2470573367","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470573367?lang=zh_cn&edition=full","pubTime":"2024-09-27 00:55","pubTimestamp":1727369747,"startTime":"0","endTime":"0","summary":" Niket  Nishant/Manya Saini    路透9月26日 - 受经济衰退担忧消退和股市飙升的推动，美国首次公开募股市场在经历了近两年的枯竭期后，于 2024 年强劲反弹。以下图表概述了 IPO 市场的现状：强劲上市根据文艺复兴资本公司的数据，今年首次公开募股募集资金至少1亿美元的公司，其交易价格平均上涨约25%，首日涨幅达16%。定位加速 复兴资本公司认为，虽然首次公开募股已从去年的低点回升，但通过此类销售募集的资金远低于10年的历史平均水平。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RDDT","BIOA","BK4224","IPO","CON","LINE","BK4185"],"gpt_icon":0},{"id":"2470541857","title":"更新版 1-投资者押注减肥药热潮，BioAge 首次亮相估值 7.58 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470541857","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470541857?lang=zh_cn&edition=full","pubTime":"2024-09-27 00:23","pubTimestamp":1727367806,"startTime":"0","endTime":"0","summary":"     路透9月26日 - 在投资者热情高涨的背景下，BioAge Labs   周四开盘股价比首次公开发行价高出25%，这家减肥药开发商的首次亮相表现强劲。该公司在纳斯达克的首日开盘价为22.50美元，而首次公开发行价为18美元。根据PitchBook的数据，BioAge首次公开募股的估值为7.575亿美元，相比之下，该公司在2月份的一轮融资 ，融资额为3.943亿美元。BioAge在两次扩大 ，共售出1100万股，比原计划多出46.7%，融资1.98亿美元。 的发行价为市场定价区间 17 美元至 19 美元的中点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA"],"gpt_icon":0},{"id":"2470522927","title":"更新版 2-投资者押注减肥药热潮，BioAge 首次亮相估值 7.58 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470522927","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470522927?lang=zh_cn&edition=full","pubTime":"2024-09-27 00:23","pubTimestamp":1727367806,"startTime":"0","endTime":"0","summary":"更新版 2-投资者押注减肥药热潮，BioAge 首次亮相估值 7.58 亿美元添加第 6 段中的公司背景和分析师评论Arasu Kannagi Basil/Prakhar Srivastava. 路透9月26日 - 周四，在投资者热情高涨的背景下，BioAge Labs BIOA.O的股价较其首次公开发行价高出25%，这家减肥药开发商的首次亮相表现强劲。BioAge在两次扩大 ，共售出1100万股，比原计划多出46.7%，融资1.98亿美元。BioAge 公司称，Azelaprag 与 GLP-1 药物联用一年后，体重有可能减轻 20% 以上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240926:nL4S3L81NT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA"],"gpt_icon":0},{"id":"2470545397","title":"减肥药开发商 BioAge 在纳斯达克首次上市估值 7.58 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470545397","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470545397?lang=zh_cn&edition=full","pubTime":"2024-09-27 00:17","pubTimestamp":1727367423,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透9月26日 - 周四，BioAge Labs   在纳斯达克首次上市，开盘价比首次公开发行价高出25%，这家减肥药开发商的估值为7.575亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QID","BK4007","QLD","SQQQ",".IXIC","ARTL","BIOA","MNQmain","NQmain","TQQQ","PSQ"],"gpt_icon":0},{"id":"1174058188","title":"异动解读 | BioAge Labs Inc.(BIOA.US)股价大涨25% 获资本市场看好减肥药研发前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1174058188","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174058188?lang=zh_cn&edition=full","pubTime":"2024-09-27 00:16","pubTimestamp":1727367379,"startTime":"0","endTime":"0","summary":"在纳斯达克交易的生物科技公司BioAge Labs Inc. 股价今日大涨25%,引发了市场的广泛关注。从公司最新消息来看,这与其正在积极筹备的首次公开募股有直接关联。据悉,BioAge Labs计划以每股18美元的价格发行1100万股新股,募集资金高达1.98亿美元。BioAge Labs的主打产品Azelaprag是一种口服小分子药物,已在8个1期临床试验中展现出良好的安全性和耐受性。公司目前正在开展Azelaprag与现有减肥药联合用药的2期临床试验,有望成为全口服肥胖症联合疗法。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | BioAge Labs Inc.(BIOA.US)股价大涨25% 获资本市场看好减肥药研发前景","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BIOA"],"gpt_icon":0},{"id":"2470675101","title":"BIOAGE LABS在纳斯达克上市首日开盘报22.50美元，较18美元的首次公开募股（IPO）价格上涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2470675101","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470675101?lang=zh_cn&edition=full","pubTime":"2024-09-27 00:15","pubTimestamp":1727367324,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["SQQQ","PSQ","BIOA","IPO","ARTL","03086","NDX","QID",".IXIC","BK4007","TQQQ","QLD","MNQmain","BK1147","QQQ","159632","NQmain"],"gpt_icon":0},{"id":"2470813206","title":"减肥药研发公司BioAge Labs(BIOA.US)扩大发行规模至1100万股 IPO定价18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470813206","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470813206?lang=zh_cn&edition=full","pubTime":"2024-09-26 15:59","pubTimestamp":1727337555,"startTime":"0","endTime":"0","summary":"生物科技初创公司BioAge Labs正在筹划通过首次公开发行(IPO)筹集高达1.98亿美元的资金。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20240926/20240926155504_53537.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240926/20240926155504_53537.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1187478.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BIOA"],"gpt_icon":0},{"id":"2468083543","title":"生物科技初创公司BioAge Labs(BIOA.US)IPO定价17-19美元/股 拟筹资1.35亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468083543","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468083543?lang=zh_cn&edition=full","pubTime":"2024-09-19 14:50","pubTimestamp":1726728600,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，生物科技初创公司BioAge Labs于周三公布了其 IPO 条款，该公司计划以 17 至 19 美元的价格区间发行 750 万股股票，筹集 1.35 亿美元。按照提议的范围的中间值，BioAge Labs 的市值将达到 6.02 亿美元。BioAge Labs的主要关注点是代谢疾病，这是全球最大的医疗保健挑战之一。BioAge Labs的主要候选产品 Azelaprag是一种口服小分子，在8个 1 期临床试验中，265 名受试者的耐受性良好。BioAge Labs在2022年、2023年运营亏损分别为3997万美元、4840万美元;净亏损分别为3972万美元、6385万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1184507.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BIOA","159837"],"gpt_icon":0}],"profile":{"websiteUrl":"http://bioagelabs.com","stockEarnings":[{"period":"1week","weight":-0.1758},{"period":"1month","weight":-0.2433},{"period":"3month","weight":0.0161},{"period":"ytd","weight":0.0161}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BioAge Labs, Inc.于2015年4月1日在特拉华州注册成立。他们是一家临床阶段的生物制药公司，通过针对人类衰老的生物学特性，开发治疗肥胖等代谢性疾病的候选产品。他们的技术平台和差异化的人类数据集使他们能够根据对驱动衰老的分子变化的见解来识别有前景的靶点。他们的主要关注点是代谢性疾病，这是全球最大的医疗保健挑战之一。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.008123},{"month":2,"riseRate":0.4,"avgChangeRate":-0.16094},{"month":3,"riseRate":0.2,"avgChangeRate":-0.091972},{"month":4,"riseRate":0.4,"avgChangeRate":-0.044244},{"month":5,"riseRate":0,"avgChangeRate":-0.19738},{"month":6,"riseRate":0.25,"avgChangeRate":0.003055},{"month":7,"riseRate":0.4,"avgChangeRate":-0.005696},{"month":8,"riseRate":0.4,"avgChangeRate":-0.229124},{"month":9,"riseRate":0.6,"avgChangeRate":0.004924},{"month":10,"riseRate":0.8,"avgChangeRate":0.181962},{"month":11,"riseRate":0.6,"avgChangeRate":0.056827},{"month":12,"riseRate":0.2,"avgChangeRate":-0.087267}],"exchange":"NASDAQ","name":"BioAge Labs Inc.","nameEN":"BioAge Labs Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioAge Labs Inc.(BIOA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioAge Labs Inc.(BIOA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioAge Labs Inc.,BIOA,BioAge Labs Inc.股票,BioAge Labs Inc.股票老虎,BioAge Labs Inc.股票老虎国际,BioAge Labs Inc.行情,BioAge Labs Inc.股票行情,BioAge Labs Inc.股价,BioAge Labs Inc.股市,BioAge Labs Inc.股票价格,BioAge Labs Inc.股票交易,BioAge Labs Inc.股票购买,BioAge Labs Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioAge Labs Inc.(BIOA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioAge Labs Inc.(BIOA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}